Clinical assessment of human gonadotrophins produced by recombinant DNA technology

Human Reproduction

Volumn 11, Issue SUPPL. 1, 1996, Pages 95-107

  Loumaye, Ernest ^a   Martineau, Isabelle ^a   Piazzi, Angela ^a   O'Dea, Louis ^b   Ince, Susan ^a   Howies, Colin ^a   Decosterd, Geneviève ^a   Van Loon, K Van ^a   Galazka, A ^a  

^a Serono International SA   (Switzerland)

^b Serono Inc   (United States)

Author keywords

Anovulation; Gonadotrophins; Hypogonadotrophic hypogonadism; IVF; PCOD

Indexed keywords

CHORIONIC GONADOTROPIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT HORMONE; RECOMBINANT LUTEINIZING HORMONE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; CHO CELL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MANUFACTURE; DRUG PURITY; DRUG SAFETY; EUKARYOTIC CELL; FEMALE; GENETIC PROCEDURES; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OVARY FOLLICLE DEVELOPMENT; OVULATION; PREGNANCY; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION; SUPEROVULATION;

CRICETINAE; CRICETULUS GRISEUS; EUKARYOTA;

EID: 0030317036     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/11.suppl_5.95     Document Type: Conference Paper

References (53)

1. Bustillo, M. (1995) Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil. Steril., 64, 13-21.
2. Butt, W.R. (1988) Gonadotrophins in the treatment of infertility. Acta Endocrinol., 288, 51-57.
3. Buvat, J., Buvat-Herbaut, M., Marcolin, G. et al. (1989) Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil Steril., 52, 553-559.
4. Catt, K.J. and Dufau, M.L. (1991) Gonadotropic hormones: biosynthesis, secretion, receptors and actions. In Yen, S.C. and Jaffe, R.B. (eds), Reproductive Endocrinology.
5. Chappel, S., Kelton, C. and Nugent, N. (1992) Expression of human gonadotropins by recombinant DNA methods. In Genazzi, A.R. and Petraglia, F. (eds), Proceedings of the 3rd Congress on Gynecological Endocrinology Parthenon Publishing Group, Carnforth. pp. 179-184.
6. Couzinet, B., Lestrat, N., Brailly. S. et al. (1988) Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonaclotrophin deficiency. J. Clin. Endocrinol. Metab., 66, 552-556.
7. Daya, S., Gunby, J., Hughes. E.G. et al. (1995) Follicle stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil. Steril., 64, 347-354.
8. Devroey P., Mannaerts B., Smitz J. et al. (1994) Clinical outcome of a pilot efficacy study on recombinant human follicle stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum. Reprod., 9, 1064-1069.
9. Diczfalusy, E. and Harlin, J. (1988) Clinical-pharmacological studies on human menopausal gonadotrophin. Hum. Reprod., 3, 21-27.
10. FIVNAT (1995) Pregnancies and births resulting from in vitro fertilization: French national registry. analysis of data 1986 to 1990. Fertil. Steril., 64, 746-756.
11. Fox, R., Corrigan, E., Thomas, P. and Hull, M. (1991) The diagnosis of polycystic ovaries in women with oligo-amenorrhea: predictive power of endocrine tests. Clin. Endocrinol., 34, 127-131.
12. Fulghesu A.M., Guida C., Nicoletti C.L. et al. (1990) Induction of ovulation in PCOD patients: use of GnRH analogs combined to gonadotrophins. In Adashi. E.Y. and Mancuso, S. (eds), Serono Symposia Vol. 73: Major Advances in Human Female Reproduction. Raven Press, New York, p. 389.
13. Franks, S. (1989) Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol., 31, 87.
14. Gadir, A.A., Mowafi, R.S., Alnaser, H.M.I, et al. (1990) Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin. Endocrinol., 33, 585-592.
15. Gemzell, C.A., Diczfaluzy, E., Tillinger, K.G. (1960) Human pituitary follicle-stimulating hormone I: clinical effect of a partly purified preparation. Ciba Found. Colloq. Endocrinol., 13, 191.
16. Germond, M., Dessole, S., Senn, A. et al. (1992) Successful in-vitro fertilization and embryo transfer after treatment with recombinant human FSH. Lancet, 338, 1170.
17. Hamilton-Fairley, D., Kiddy, D., Watson, H. et al. (1991) Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum. Reprod., 6, 1095-1099.
18. Homburg, R., Eshel, A., Kilborn, J. et al. (1990) Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum. Reprod., 5, 32-35.
19. Hornnes, P., Giroud, D., Howles, C. and Loumaye, E. (1993) Recombinant human folliclestimulating hormone treatment leads to normal follicular growth, estradiol secretion, and pregnancy in a World Health Organization group II anovulatory woman. Fertil. Steril., 60, 724-726.
20. Hughes, E.G., Fedorkow, D.M., Daya, S. et al. (1992) The routine use of gonadotropin-releasing hormone agonists prior to IVF and gamete intratallopian transfer: a meta-analysis of randomised controlled trials. Fertil. Steril., 58, 888-896.
21. Hull, M., Corrigan, E., Piazzi, A. and Loumaye, E. (1994) Successful ovulation induction and pregnancy by treatment with recombinant human LH in a hypogonadotropic women. Lancet, 344, 334-335.
22. Keene, J.L., Matzuk, M.M., Otani, T. et al. (1989) Expression of biologically active human follitropin in Chinese hamster ovary cells. J. Biol. Chem., 264, 4769-4775.
23. Kousta, E., White, D.M., Piazzi, A. et al. (1996) Successful induction of ovulation and completed pregnancy using r-hLH and r-hFSH in a woman with Kallmann's syndrome. Hum. Reprod., 11, 70-71.
24. Larsen, T., Larsen, J.F., Schioler, V. et al. (1990) Comparison of urinary human follicle stimulating hormone and human menopausal gonadotrophin for ovarian stimulation in polycystic ovarian syndrome. Fertil. Steril., 53, 426-431.
25. Le Cotonnec, J.-Y., Porchet, H., Beltrami, V. et al. (1994a) Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH) I. Comparative pharmacokinetics with urinary human FSH. Fertil. Steril., 61, 669-678.
26. Le Cotonnec, J.-Y., Porchet, H.C., Beltrami, V. et al. (1994b) Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics. Fertil. Steril., 61, 679-686.
27. Loumaye, E., Campbell, R. and Salat-Baroux, J. (1995) Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum. Reprod. Update, 1, 188-199.
28. Lunenfeld, B., Sulimovici, S., Rabau, E. and Eshkol, A. (1962) L'induction de l'ovulation dans les aménorrhées hypophysaires par un traitement combiné de gonadotrophines urinaires ménopausiques et de gonadotrophines chorioniques. C.R. Société Fr. Gynécol., 5, 30.
29. Mannaerts, B., De Leeuw, R., Geelen, J. et al. (1991) Comparative in vitro and in vivo studies on the characteristics of recombinant human follicle-stimulating hormone. Endocrinology, 129, 2623-2630.
30. O'Dea, L. (for US Multicenter Trial Group), Loumaye, E. and Liu, H. (1993) A randomized, comparative multicenter, clinical trial of recombinant and urinary human FSH in in vitro fertilization and Embryo Transfer (IVF-ET). The American Fertility Society/The Canadian Fertility and Andrology Society 1993 Annual Meeting. Fertil. Steril. (Programme supplement). Abstr. 0-106.
31. Out, H.J., Mannaerts, B.M.J.L., Driessen, S.G.A.J. and Coelingh Bennink, H.J.T. (1995) A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
32. Porchet, H.C., Le Cotonnec, J., Canali, S. and Zanolo, G. (1993) Pharmacokinetics of r-hFSH after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary FSH. Drug Metab. Disp., 21, 144-150.
33. Porchet, H.C., Le Cotonnec, J.-Y., and Loumaye, E. (1994) Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration. Fertil. Steril., 61, 687-695.
34. Porchet, H.C., Le Cotonnec, J.-Y., Neuteboom, B. et al. (1995) Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J. Clin. Endocrinol. Metab., 80, 667-673.
35. Quinton, R., Matfin, G., Bouloux, P. and Loumaye, E. (1994) Successful induction of fertility in a hypogonadotropic male. Lancet, 343, 733.
36. Recombinant FSH Study Group (1995) Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil. Steril., 63, 77-86.
37. Sagle, M A., Hamilton-Fairley, D., Kiddy, D. and Franks, S. (1991) A comparative, randomized study of low dose human menopausal gonadotrophin and follicle stimulating hormone in women with polycystic ovarian syndrome. Fertil. Steril., 55, 56-60.
38. Schoot, D.C., Coelingh Bennink, H.J.T., Mannaerts, B.M.J.L. et al. (1992) Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in man with isolated gonadotropin deficiency. J. Clin. Endocrinol. Metab., 74, 1471-1473.
39. Schoot, D.C., Harlin, J., Shoham, Z. et al. (1994) Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum. Reprod., 9, 1237-1242.
40. Seibel, M.M., McArdle, C., Smith, D. and Taymor, M.L. (1985) Ovulation induction in PCOS with u-hFSH or hMG. Fertil. Steril., 43, 703-708.
41. Shoham, Z., Di Carlo, C., Patel, A., Conway, G.S. and Jacobs, H. (1991a) Is it possible to run a successful ovulation induction program based solely on ultrasound monitoring. Fertil. Steril., 56, 836-840.
42. Shoham, Z., Balen, A., Patel, A. and Jacobs, H. (1991b) Results of ovulation induction using human menopausal gonadotrophin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil. Steril., 56, 1048-1053.
43. Shoham Z., Patel A. and Jacobs H. (1991c) Polycystic ovarian disease syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle stimulating hormone. Fertil. Steril., 55, 1051-1056.
44. Shoham, Z., Balen, A., Patel, A. and Jacobs, H.S. (1991d) HMG versus purified FSH in hypogonadism. Fertil. Steril., 56, 1048-1053.
45. Shoham, Z., Loumaye, E. and Piazzi, A. (1995) A dose finding study to determine the effective dose of recombinant human luteinizing hormone to support FSH-induced follicular development in hypgonadotropic hypogonadal (HH) women. 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, USA. Abstr. 0-142.
46. Speroff L., Glass R.H., Kase N.G. (1989) Clinical Gynecologic Endocrinology and Infertility. 3rd edn. Williams and Wilkins, Baltimore, pp. 583-609.
47. van Weissenbruch, M.M., Schoemaker H.C., Drexhage H.A., Schoemaker J. (1993) Pharmacodynamics of human menopausal gonadotrophin (HMG) and follicle stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease. Hum. Reprod., 8, 813-821.
48. Van de Wiele, R., Bogumi, J., Dyrenfurth, I. et al. (1970) Mechanisms regulating the menstrual cycle in women. Hormone Res., 26, 63-103.
49. Venturoli S., Paradisi R., Fabbri R. et al. (1987) Induction of ovulation in polycystic ovary: human menopausal gonadotrophin or human urinary follicle stimulating hormone? Int. J. Fertil., 32, 66.
50. World Health Organization (1973) Agents stimulating gonadal function in the human. Report of a WHO scientific group. Wld. Hlth. Org. Techn. Rep. Ser., 514.
51. Wikland, M., Borg J., Hamberger L. and Svalander, P. (1994) Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for superovulation. Hum. Reprod., 9, 1430-1436.
52. Whitcomb, R.W. and Crowley, W.F. (1990) Clinical review 4: Diagnosis and treatment of isolated gonadotropin releasing-hormone deficiency in men. J. Clin. Endocrinol. Metab., 70, 3-7.
53. Yen, S.S.C., Llerena, O., Little, B. and Pearson, O.H. (1968) Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropins in man. J. Clin. Endocrinol. Metab., 28, 1763-1767.